- New ETFs
- Bond ETFs
- Currency ETFs
- Emerging Market ETFs
- Commodity ETFs
- Broad U.S. Equity ETFs
- Sector ETFs
- Specialty ETFs
SPR Reports Disappointing Q4 Results, 2010 Guidance
Recent Articles by Monica Gerson
- TARP Repayments, Rating Upgrades Give Financials A Facelift (HIG, DFS, UNM, LNC, GGP, SPG, CIT)
- Credit Suisse Adds BLK To US Focus List
- ATHN Has Strong Long Term Outlook
- SQNM Likely To Develop High Margin Diagnostic Products
- ADBE Benefits From CS5 Product Launch
Analyst Color
- Massey Energy Company (MEE) Maintains Market Perform Rating
- Aerospace & Defense Industry Update (LLL, BA, RTN, SPR, ESL)
- Sell Rating Maintained For Mercury General Corporation (MCY)
- CIT Group Inc. (CIT) Maintains Buy Rating
- Accenture’s (ACN) Estimates Lowered
Price Target
- Aerospace & Defense Industry Update (LLL, BA, RTN, SPR, ESL)
- ATHN Has Strong Long Term Outlook
- OpenTable Inc.’s (OPEN) Price Target Raised
- MYR Group Inc.’s (MYRG) Price Target Raised
- Bank of America (BAC) To Benefit From 4Cs
Analyst Ratings
Posted on 02/05/10 at 1:52pm by Monica Gerson
Analysts at JP Morgan maintain their "neutral" rating on Spirit AeroSystems (NYSE: SPR), while reducing their estimates for the company. The target price for SPR has been reduced from $19 to $18.
Spirit AeroSystems reported its Q4 EPS significantly short of the estimates due to surprise charges and weak cash flows. SPR has issued a disappointing guidance for 2010.
“We do not see the issues raised in Q4 - risk of surprise charges, lack of margin visibility, and weak cash flow - going away soon, and we therefore remain cautious on the stock,” the analysts add. JP Morgan has reduced its EPS estimates for FY10 and FY11 from $1.90 to $1.65 and from $1.75 to $1.65, respectively.
Bookmark/Search this post with:
Related Articles
Today's Trading Ideas
Featured Articles
Related News from the Stock Market
- Aerospace & Defense Industry Update (LLL, BA, RTN, SPR, ESL)
- Spirit AeroSystems Named to Boeing Tanker Supplier Team
- Evotec Signs High Throughput Screening Agreement With Active Biotech
- China Medical Technologies Reports Third Fiscal Quarter Financial Results
- Evotec Extends and Broadens Research Agreement With Cubist Pharmaceuticals
There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.
Post new comment
Receive Benzinga's Best 2010 Stock Idea!
